| Identification | Back Directory | [Name]
JY-3-094 | [CAS]
389076-27-1 | [Synonyms]
JY-3-094
4-(7-Nitro-benzo[1,2,5]oxadiazol-4-ylamino)-benzoicacid
Benzoic acid, 4-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]- | [Molecular Formula]
C13H8N4O5 | [MOL File]
389076-27-1.mol | [Molecular Weight]
300.23 |
| Chemical Properties | Back Directory | [Boiling point ]
569.0±60.0 °C(Predicted) | [density ]
1.638±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
4.14±0.10(Predicted) | [color ]
Orange to red |
| Hazard Information | Back Directory | [Uses]
JY-3-094 is a Myc inhibitor that inhibits Myc-Max heterodimer formation (IC50: 33 μM)[1]. | [References]
[1] Yap JL, et al. Pharmacophore identification of c-Myc inhibitor 10074-G5. Bioorg Med Chem Lett. 2013 Jan 1;23(1):370-4. DOI:10.1016/j.bmcl.2012.10.013 |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310; |
| Website: |
https://www.weikeqi-biotech.com/ |
|